← Back to Search

Treatment Group for Atrial Fibrillation

N/A
Waitlist Available
Research Sponsored by Newmarket Electrophysiology Research Group Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Summary

This study aims to investigate the effect of MUSE (R) Headbands on patients with Atrial Fibrillation who is awaiting pulmonary vein isolation ablation procedure. Patients are randomized in 2 arms. The control arm will not be receiving the MUSE headband, whereas the treatment group obtains a device. Patients from both group will fill out a quality-of-life questionnaire at the time of enrollment and 3 months post PVI. Results from both arms will be evaluated and ultimately the effect of mindfulness using the headband will be evaluated in the aforementioned patient population.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Quality of Life

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment GroupExperimental Treatment1 Intervention
These patients will receive the device. they are expected to use it for at least 5 minutes per day. Patients in this arm will fill out a quality of life questionnaire at the time of enrollment and 3 months after their procedure.
Group II: ControlActive Control1 Intervention
These patients will not receive a device, but have to fill out a quality of life questionnaire at the time of enrollment and 3 months after their procedure.

Find a Location

Who is running the clinical trial?

Newmarket Electrophysiology Research Group IncLead Sponsor
3 Previous Clinical Trials
430 Total Patients Enrolled
2 Trials studying Atrial Fibrillation
430 Patients Enrolled for Atrial Fibrillation
Atul Verma, MDStudy DirectorNewmarket Electrophysiology Research Group
12 Previous Clinical Trials
3,032 Total Patients Enrolled
11 Trials studying Atrial Fibrillation
3,007 Patients Enrolled for Atrial Fibrillation
~6 spots leftby Jul 2025